# Commission Implementing Decision (EU) 2019/769 of 14 May 2019 amending Implementing Decision 2012/715/EU establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

‘ANNEX
List of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union
Hereafter understood as the State of Israel, excluding the territories under Israeli administration since June 1967, namely the Golan Heights, the Gaza Strip, East Jerusalem and the rest of the West Bank.
Third country
Remarks
Australia
Brazil
Israel
Japan
Republic of Korea
Switzerland
United States of America
’

---
Source: https://www.legislation.gov.uk/eudn/2019/769/annex (the official version)
Page: https://openlegislation.uk/eu-decision-2019-769/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.